doxapram has been researched along with methohexital in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, CJ; MacGregor, DM; Robertson, GS | 1 |
Cheney, D; Duffey, H; Hughes, K; Watson, R | 1 |
Brown, MB; Dugat, DR; Lyon, SD; Nafe, LA; Payton, ME; Peakheart, SK; Salazar, RS | 1 |
1 review(s) available for doxapram and methohexital
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for doxapram and methohexital
Article | Year |
---|---|
Evaluation of doxapram for arousal from general anaesthesia in outpatients.
Topics: Anesthesia, Inhalation; Anesthetics; Arousal; Clinical Trials as Topic; Doxapram; Female; Halothane; Humans; Male; Methohexital; Nitrous Oxide | 1977 |
3 other study(ies) available for doxapram and methohexital
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A clinical and pharmacological approach to neurolepsis and its reversal in oral surgery.
Topics: Benperidol; Central Nervous System; Doxapram; Fentanyl; Humans; Levallorphan; Methohexital; Neuroleptanalgesia; Tranquilizing Agents | 1971 |
Comparison of methohexital and propofol as induction agents for evaluation of laryngeal function in healthy dogs.
Topics: Anesthetics, Intravenous; Animals; Dogs; Doxapram; Female; Larynx; Male; Methohexital; Physical Examination; Propofol; Random Allocation; Respiratory System Agents; Treatment Outcome | 2019 |